AMR GRANDCHALLENGE

Achieving breakthroughs on Antimicrobial Resistance treatments & diagnostics

WHAT IS AT
STAKE ?

Discovered almost a century ago, antibiotics have saved countless lives and revolutionized medicine. But antimicrobial resistance (AMR) is making those antibiotics less efficient, and no major discoveries have been made in the last decades. An estimated 700,000 people lose their live every year due to AMR, and this number could skyrocket to 10 million in 2050.

We need new treatments and new diagnostics to tackle AMR, the silent pandemic. This is a One Health global issue.

>WHAT IS THE GRANDCHALLENGE ABOUT

The Joint European Disruptive Initiative, the European ARPA,
will launch scientific & technology Challenges around:

NEW ANTIBIOTICS THROUGH AI.png

NEW  ANTIBIOTICS  THROUGH AI

PHAGE THERAPY.png

PHAGE THERAPY

VACCINES TARGETING AMR.png

VACCINES  TARGETING  AMR

DISTINGUISHING BACTERIAL FROM VIRAL INFECTIONS.png

DISTINGUISHING BACTERIAL FROM VIRAL INFECTIONS

AMR  DATA-GATHERING.png

AMR  DATA GATHERING

UNIVERSAL DIAGNOSTICS FOR AMR & OTHER DISEASES.png

UNIVERSAL DIAGNOSTICS FOR AMR & OTHER DISEASES

michael-afonso-rR95ZJbFE14-unsplash.jpg

Starting soon, we will be welcoming all proposals from the best teams globally that can provide solutions to one of the 6 Challenges listed above.

We will then finetune specific JEDI Challenges with highly-ambitious metrics for success, that will be launched in 2022.

>HOW TO CONTRIBUTE

             With bold ideas & proposals

 

As a public or private strategic partner